An interventional study of Alcohol in Alcohol Intoxication, sponsored by University of Washington. Completed at 1 site in United States. Open to participants aged 21 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-17.
Sponsored by University of Washington · Not applicable, Interventional, and Basic science
The goal of this clinical trial is to examine how alcohol affects young adults' attention in both laboratory and real-world settings through phone-based cognitive tasks. The main questions this trial is designed to answer are:
Participants will complete cognitive tasks to assess attention before and after consuming a standard amount of alcohol in the laboratory, and during surveys completed through a phone app for eight weekends.
The goal of this study is to develop cognitive tasks that assess alcohol-related attentional narrowing (i.e., alcohol myopia) for smartphone-based ecological momentary assessment (EMA). In Phase I, tasks were adapted from computer to smartphone format and refined through interviews with young adults who provided feedback on mock-ups. In Phase II (the current trial), feasibility, acceptability, reliability, and validity of the adapted tasks will be tested in lab and EMA. Young adults who pass an online pre-screening and phone screening will complete an initial lab session involving self-report questionnaires, alcohol consumption (target breath alcohol concentration [BrAC] = .08%), and general cognitive and myopia-specific tasks. All participants in Phase II will be assigned to receive a dose of alcohol in the lab session; task performance will be compared within individuals from before to after they are intoxicated. Participants will remain in the lab until their BrAC reduces to a level of .03% and they can pass a field sobriety test. These same participants will then complete EMA while wearing transdermal alcohol biosensors for 8 consecutive weekends, including one morning survey and at least two evening surveys per day. Then, participants will return to the lab for a follow-up session involving self-report questions and an interview eliciting additional feedback. Findings will help to clarify the role of alcohol myopia as a mechanism linking intoxication to real-world risk behaviors.
76 studies on the registry are indexed under Alcoholic Intoxication; 17 are open to participants now.
This study's enrollment of 92 is below the median of 135 across 62 interventional studies indexed under Alcoholic Intoxication.
Browse Alcoholic Intoxication studies →University of Washington is the lead sponsor of 1,433 studies on the registry; 225 are open to participants now.
Of its 158 completed or terminated interventional studies of FDA-regulated products, 136 (86%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Alcohol
A standard dose of alcohol will be administered (volume calculated with regard to age, sex assigned at birth, height, and weight) in the form of vodka and combined with mixer at a 1:4 ratio to reach a target breath alcohol concentration of .08%.
Central Counting Task (phone)
On a phone, participants will count the number of times a crosshair flashes in the center of the screen. Each trial will include between 1 and 4 flashes. There will be 6 trials per block. After a training block, there will be two blocks administered while sober. After alcohol consumption, three blocks will be administered on the ascending limb of the BrAC curve. Number of accurate responses will be evaluated.
Time frame: Baseline and after alcohol consumption in the laboratory (an average of approximately 1 hour after baseline)
Peripheral Probe Identification Task (phone)
While counting the number of times a crosshair flashes in the center of a phone screen (central counting task), participants will also be asked to monitor a cued corner (if possible), and shown an array of four colored stimuli. In each trial, they will be asked to identify whether the color of a probe matches the cued stimulus, with a 50% likelihood of matching. After a training block, there will be two blocks administered while sober. After alcohol consumption, three blocks will be administered on the ascending limb of the BrAC curve. Number of accurate responses will be evaluated.
Time frame: Baseline and after alcohol consumption in the laboratory (an average of approximately 1 hour after baseline)
Visual Categorization Task (phone)
On a phone, participants will be presented with one of two visual stimuli (shapes) in a random sequence with equal probability, and asked to categorize each stimuli as quickly as possible (e.g., "Is this a square or circle?") with placement of response buttons (right or left side of screen) randomized. Each trial consists of a shape categorization. There are 12 trials per block. After a training block, there will be two blocks administered while sober. After alcohol consumption, three blocks will be administered on the ascending limb of the BrAC curve. Differences in response time will be evaluated for one-back stimuli (change vs. no change) and two-back stimuli (change vs. no change).
Time frame: Baseline and after alcohol consumption in the laboratory (an average of approximately 1 hour after baseline)
Central Counting Task (desktop)
On a phone, participants will count the number of times a crosshair flashes in the center of the screen. Each trial will include between 1 and 4 flashes. A training block of 12 trials will be administered while sober. After alcohol consumption, two blocks of 120 trials each will be administered on the ascending limb of the BrAC curve. Number of accurate responses will be evaluated.
Time frame: Baseline and after alcohol consumption in the laboratory (an average of approximately 1 hour after baseline)
Peripheral Probe Identification Task (desktop)
While counting the number of times a crosshair flashes in the center of a desktop screen (central counting task), participants will also be asked to monitor a cued corner (if possible), and shown an array of four colored stimuli. In each trial, they will be asked to identify whether the color of a probe matches the cued stimulus, with a 50% likelihood of matching. A training block of 12 trials will be administered while sober. After alcohol consumption, two blocks of 120 trials each will be administered on the ascending limb of the BrAC curve. Number of accurate responses will be evaluated.
Time frame: Baseline and after alcohol consumption in the laboratory (an average of approximately 1 hour after baseline)
Auditory Categorization Task (desktop)
On a desktop, participants will be presented with one of two auditory stimuli (high and low tones) in a random sequence with equal probability, and asked to categorize each stimuli as quickly as possible with placement of response options (shown on right or left side of screen) randomized. Each trial consists of a shape categorization. A training block of 12 trials will be administered while sober. After alcohol consumption, five blocks of 100 trials each will be administered on the ascending limb of the BrAC curve. Differences in response time will be evaluated for one-back stimuli (change vs. no change) and two-back stimuli (change vs. no change).
Time frame: Baseline and after alcohol consumption in the laboratory (an average of approximately 1 hour after baseline)
Plan to share: Yes — The investigators plan to share limited, de-identified datasets for the purposes of data analysis and dissemination.
Time frame: During data collection, data will be submitted biannually to the NIMH Data Archive.
Access criteria: Individual requests to access data with intended purpose should be made to Dr. Jaffe and will be reviewed by the investigative team. Requests can also be made through the NIMH Data Archive
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.